LOS ANGELES CAPITAL MANAGEMENT LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1177206
LOS ANGELES, CA
Position in GILD
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$10,238,120
-$378,709,597 QoQ
Shares Held
73,460
-97.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 68.88783011162538.ToString("F0")%
Shared 0.ToString("F0")%
None 31.112169888374623.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $1,172,096,642 across 10 Drug Manufacturers - General names. GILD ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
454,512 | $418,046,502 | |
| 2 | ABBV |
AbbVie Inc.
|
1,260,942 | $274,242,275 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,257,069 | $258,191,234 | |
| 4 | JNJ |
Johnson & Johnson
|
369,494 | $90,319,113 | |
| 5 | AMGN |
Amgen Inc
|
187,621 | $66,014,448 | |
| 6 | PFE |
Pfizer Inc
|
1,112,386 | $31,235,798 | |
| 7 | MRK |
Merck & Co., Inc.
|
131,751 | $15,848,327 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
73,460 | $10,238,120 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,238,120 | 73,460 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $388,947,717 | 3,168,875 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $426,837,069 | 3,845,379 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $290,643,931 | 2,621,484 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $282,706,183 | 2,523,036 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $44,593,926 | 482,775 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $34,965,723 | 417,053 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $46,585,435 | 678,989 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $103,821,180 | 1,417,354 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $116,413,881 | 1,437,031 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $70,138,294 | 935,926 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $23,218,647 | 301,267 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $43,980,737 | 530,080 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $196,187,596 | 2,285,237 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $131,383,043 | 2,129,730 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $122,034,820 | 1,974,354 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $117,830,375 | 1,982,008 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $89,267,750 | 1,229,414 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $41,090,869 | 588,273 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $48,923,033 | 710,471 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $51,561,814 | 797,800 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $27,812,799 | 477,391 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $30,173,477 | 477,504 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $30,205,720 | 392,588 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $11,433,869 | 152,941 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||